Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related CREE
Watch These 10 Huge Call Purchases In Friday Trade
Najarian Brothers See Unusual Options Activity In Cree And Liberty Interactive
Related CI
Market Shakes As Republicans Accept Defeat On Healthcare Bill
Trump, House Republicans Seek Delay In Healthcare Ruling - Because They're Afraid They'll Win
Must What Went Up Now Come Down? (Seeking Alpha)

Analysts at Sterne Agee downgraded Cree (NASDAQ: CREE) from “buy” to “neutral.” The target price for Cree has been lowered from $66.00 to $59.00. Cree's shares closed at $61.11 yesterday.

Analysts at Jefferies downgraded Cigna (NYSE: CI) from “buy” to “hold.” The target price for Cigna has been lowered from $78.00 to $75.00. Cigna's shares closed at $69.03 yesterday.

Analysts at Stifel Nicolaus downgraded Crimson Exploration (NASDAQ: CXPO) from “buy” to “hold.” The target price for Crimson Exploration is set to $3.75. Crimson Exploration's shares closed at $3.14 yesterday.

Goldman Sachs downgraded AVG Technologies N.V. (NYSE: AVG) from “buy” to “neutral.” The target price for AVG Technologies has been raised from $18.00 to $18.50. AVG Technologies' shares closed at $17.48 yesterday.

Latest Ratings for CREE

DateFirmActionFromTo
Feb 2017JMP SecuritiesDowngradesMarket OutperformMarket Perform
Dec 2016JMP SecuritiesInitiates Coverage OnMarket Outperform
Oct 2016Stephens & Co.DowngradesOverweightEqual-Weight

View More Analyst Ratings for CREE
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (CI + AVG)

View Comments and Join the Discussion!